Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.
The triplet therapy was effective only in patients with nonmutated PIK3CA and ESR1 genes, achieving a median PFS of 9.1 ...
Money Talks News on MSN
$32K Alzheimer drugs offer modest brain benefits
Controversial anti-amyloid therapies costing up to $32,000 annually offer modest hope for Alzheimer's patients while carrying ...
Healthcare ambulatory boom drives hospitals to treat sicker patients and redesign inpatient care models for efficiency and safety.
News Medical on MSN
Sertraline contributes to a modest improvement in core depression and anxiety symptoms
One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major ...
The investigational, potentially first-in-class agent tinostamustine (EDO-S101) has earned FDA orphan drug designation (ODD) ...
In a 36-year-old woman with a resected 5-cm, node-negative, estrogen-receptor (ER)-negative, progesterone-receptor (PR)-positive, HER2-neu-negative breast cancer, is there a role for the addition of ...
ScienceAlert on MSN
Alzheimer's Disease Could Be Slowed by Taking as Few as 5,000 Steps a Day
Taking a pleasant daily stroll could help slow the protein buildup and cognitive decline associated with Alzheimer's disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results